This list is an analysis based on recent market events. It's not an investment recommendation.
About
Equasens S.A., founded in 1996 and headquartered in Villers-les-Nancy, France, is a European-based subsidiary of Marque Verte Sante that specializes in providing a wide array of information technology solutions for the healthcare sector. The company offers extensive tools for managing pharmacies and their networks, including LGPI global services and OffiCentral. To optimize pharmacists' day-to-day operations, Equasens provides specialized applications like OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker. Furthermore, its ULTIMATE system integrates pharmacy management with patient support, while FARMACLICK and DIFARM facilitate seamless communication between pharmacies and wholesale distributors. Additional retail management capabilities are offered through PHARE and the SOPHIA application. To enhance customer engagement, Equasens equips pharmacists with solutions such as OffiTag, OffiTouch, OffiMédia, OffiConnect, various automation systems, customer loyalty programs, and OffiMédia point-of-sale displays. Beyond operational management, Equasens supports professional development and strategic decision-making with My Pilot, an analytics and management tool, and OffiLearning for e-learning. Its patient-centric offerings encompass compliance monitoring software (Multimeds, Automeds), remote consultation services (OffiTéléconsult), and comprehensive systems for pharmaceutical and shared medical records. Specific solutions like eNephro target chronic renal failure patients, and TPE Pilot assists in managing patient education initiatives. The company's diverse portfolio also extends to home healthcare and nursing services, featuring products like NOVIACARE, CARELIB Domicile, CARELIB EHPAD, MICROSOINS, and the MOBISOINS mobile tool. Other specialized solutions include KAPELSE, TITAN, ANTHADINE software, and LOGICLIC. Additionally, Equasens provides AXIGATE solutions and the CHORUS platform to streamline the entire patient care pathway. It also offers medical telesecretarial services for healthcare professionals and delivers equipment lease financing options.
The current price of EQS.PA is €31.65 EUR — it has increased by +0.64% in the past 24 hours. Watch Equasens stock price performance more closely on the chart.
What is Equasens stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Euronext Paris exchange Equasens stocks are traded under the ticker EQS.PA.
Is Equasens stock price growing?▼
EQS.PA stock has fallen by -2.61% compared to the previous week, the month change is a -6.76% fall, over the last year Equasens has showed a -30.02% decrease.
What is Equasens market cap?▼
Today Equasens has the market capitalization of 480.26M
What is Equasens revenue for the last year?▼
Equasens revenue for the last year amounts to 216.75M EUR.
What is Equasens net income for the last year?▼
EQS.PA net income for the last year is 36.23M EUR.
Does Equasens pay dividends?▼
Yes, EQS.PA dividends are paid annual. The last dividend per share was 1.4 EUR. As of today, Dividend Yield (FWD)% is 4.45%.
How many employees does Equasens have?▼
As of September 09, 2026, the company has 1,462 employees.
In which sector is Equasens located?▼
Equasens operates in the Technology sector.
When did Equasens complete a stock split?▼
The last stock split for Equasens was on August 05, 2015 with a ratio of 5:1.
Where is Equasens headquartered?▼
Equasens is headquartered in Villers-lès-Nancy, France.